• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up1.16%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    3.26 Up 0.07(2.19%) 11:11AM EST - Nasdaq Real Time Price
    Analyst EstimatesGet Analyst Estimates for:
    Earnings EstCurrent Qtr.
    Dec 15
    Next Qtr.
    Mar 16
    Current Year
    Dec 15
    Next Year
    Dec 16
    Avg. Estimate-0.25-0.17-1.07-0.56
    No. of Analysts10.006.0010.0011.00
    Low Estimate-0.28-0.22-1.16-0.78
    High Estimate-0.200.00-0.880.09
    Year Ago EPS-0.44-0.28-1.23-1.07
    Revenue EstCurrent Qtr.
    Dec 15
    Next Qtr.
    Mar 16
    Current Year
    Dec 15
    Next Year
    Dec 16
    Avg. Estimate5.68M10.29M13.69M49.47M
    No. of Analysts941011
    Low Estimate4.63M5.42M13.00M29.00M
    High Estimate7.60M21.18M15.50M94.24M
    Year Ago Sales569.00K1.18M10.82M13.69M
    Sales Growth (year/est)898.20%775.70%26.50%261.40%
    Earnings HistoryDec 14Mar 15Jun 15Sep 15
    EPS Est-0.37-0.30-0.26-0.25
    EPS Actual-0.44-0.28-0.26-0.29
    Difference-0.070.020.00-0.04
    Surprise %-18.90%6.70%0.00%-16.00%
    EPS TrendsCurrent Qtr.
    Dec 15
    Next Qtr.
    Mar 16
    Current Year
    Dec 15
    Next Year
    Dec 16
    Current Estimate-0.25-0.17-1.07-0.56
    7 Days Ago-0.25-0.17-1.07-0.56
    30 Days Ago-0.25-0.17-1.07-0.55
    60 Days Ago-0.25-0.17-1.07-0.54
    90 Days Ago-0.24-0.17-1.04-0.54
    EPS RevisionsCurrent Qtr.
    Dec 15
    Next Qtr.
    Mar 16
    Current Year
    Dec 15
    Next Year
    Dec 16
    Up Last 7 Days0000
    Up Last 30 Days0000
    Down Last 30 Days0000
    Down Last 90 DaysN/AN/AN/AN/A
    Growth EstKERXIndustrySectorS&P 500
    Current Qtr.43.20%N/A-91.80%2.70%
    Next Qtr.39.30%N/AN/A13.00%
    This Year13.00%N/A110.00%2.70%
    Next Year47.70%N/A33.90%9.30%
    Past 5 Years (per annum)0.00%N/AN/AN/A
    Next 5 Years (per annum)116.20%25.99%18.94%4.88%
    Price/Earnings (avg. for comparison categories)-3.40-3.681.1423.57
    PEG Ratio (avg. for comparison categories)-0.030.140.631.67
    Currency in USD.